Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Alpha Particle Emitter"'
Autor:
Amanda G. Shea, Malick Bio Idrissou, Ana Isabel Torres, Tessa Chen, Reiner Hernandez, Zachary S. Morris, Quaovi H. Sodji
Publikováno v:
Frontiers in Nuclear Medicine, Vol 4 (2024)
Radiation therapy (RT) is a pillar of cancer therapy used by more than half of all cancer patients. Clinically, RT is mostly delivered as external beam radiation therapy (EBRT). However, the scope of EBRT is limited in the metastatic setting, where a
Externí odkaz:
https://doaj.org/article/4e5793cbbf8a4645b5099ead59e87c79
Autor:
Jenny Karlsson, Christoph A. Schatz, Antje M. Wengner, Stefanie Hammer, Arne Scholz, Alan Cuthbertson, Volker Wagner, Hartwig Hennekes, Vicki Jardine, Urs B. Hagemann
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
Targeted alpha therapy (TAT) is a promising approach for addressing unmet needs in oncology. Inherent properties make α-emitting radionuclides well suited to cancer therapy, including high linear energy transfer (LET), penetration range of 2–10 ce
Externí odkaz:
https://doaj.org/article/79d527281ca44a4b9b38e38914580781
Autor:
Valery Radchenko, Matthias M. Herth, Paul Schaffer, Matthias Barz, Vladimir Shalgunov, Gokce Engudar, Luke Wharton, Kerstin Johann, Keiran Maskell, Lennart Bohrmann
Publikováno v:
Shalgunov, V, Engudar, G, Bohrmann, L, Wharton, L, Maskell, K, Johann, K, Barz, M, Schaffer, P, Herth, M M & Radchenko, V 2022, ' Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225 Ac, and beta-particle emitter, 177 Lu ', Nuclear Medicine and Biology, vol. 104-105, pp. 11-21 . https://doi.org/10.1016/j.nucmedbio.2021.11.001
Nuclear Medicine and Biology, 104-105, 11-21
Nuclear Medicine and Biology, 104-105, 11-21
Introduction: Radiotherapy of cancer requires both alpha- and beta-particle emitting radionuclides, as these radionuclide types are efficient at destroying different types of tumors. Both classes of radionuclides require a vehicle, such as an antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a1a3a3cf7057edc511b5fc1fbd01ba
https://hdl.handle.net/1887/3250339
https://hdl.handle.net/1887/3250339
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, 10
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology 10(2020), 319
Frontiers in Oncology, 10
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology 10(2020), 319
Ovarian cancer (OC) is one of the most lethal gynecologic malignancies. Due to the lack of specific symptoms and screening methods, this disease is usually diagnosed only at an advanced and metastatic stage. The gold-standard treatment for OC patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae2d05c25055124183cb055087b7d53
Publikováno v:
Radiation Measurements. 112:1-5
At the site of the Fukushima Daiichi nuclear power plant (FDNPP), there is a large quantity of beta and gamma emitters such as 90Sr and 137Cs. Moreover, radon (Rn) progeny, which are naturally occurring radionuclides, exist and emit alpha and beta pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd62253ebcdba1108e16b6bef05a506d
https://doi.org/10.1016/j.radmeas.2018.02.003
https://doi.org/10.1016/j.radmeas.2018.02.003
Publikováno v:
Applied Radiation and Isotopes. 119:36-42
The alpha particle emitter Radium-223 dichloride (223RaCl2) has recently been approved for treatment of late-stage bone metastatic prostate cancer. There is considerable interest in studying this new agent outside of the clinical setting, however the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7daec6e8fcbb698ac001eddfcf77c917
Publikováno v:
Radiation Physics and Chemistry. 183:109387
Radioactive materials ionize air surrounding them and produce molecules such as ozone and nitrogen oxides. Concentrations of these species above background can serve as a marker for radioactive materials and provide a means for stand-off detection of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::988834316488247fbe45edf67fdf93e0
https://doi.org/10.1016/j.radphyschem.2021.109387
https://doi.org/10.1016/j.radphyschem.2021.109387
Autor:
William Kevin Kelly, Guru Sonpavde, Russell Z. Szmulewitz, A. Oliver Sartor, Benjamin E. Leiby, Zachary L. Quinn, David J. Einstein, Eddy S. Yang
Publikováno v:
Journal of Clinical Oncology. 39:5036-5036
5036 Background: Rad is an alpha particle emitter that causes DNA double strand breaks and has been FDA-approved for use in mCRPC pts with bone metastases. PARP-1 activity critically supports androgen receptor (AR) activity in mCRPC and potentiates A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::733c5374afa80b4a7f0cfac112605942
https://doi.org/10.1200/jco.2021.39.15_suppl.5036
https://doi.org/10.1200/jco.2021.39.15_suppl.5036
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Juha Toivonen, Thomas Kerst
Luminescence in air induced by alpha particle emitters can be used to optically detect radioactive contamination from distances that surpass the range of the alpha radiation itself. Alpha particles excite nitrogen molecules in air and the relaxation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5fbae615840138b8a05c099302fdda0
http://hdl.handle.net/10138/289725
http://hdl.handle.net/10138/289725